Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now

SEBI allows acceptance of client securities as collateral by way of title transfer till August 31

In a circular, the Securities and Exchange Board of India (Sebi) said the mechanism of pledge and re-pledge will be implemented with effect from August 1.

July 29, 2020 / 08:49 PM IST

Markets regulator Sebi on Wednesday allowed co-existence of the current title transfer collateral mechanism and the new pledge and re-pledge process till August 31. The decision has been taken in view of the prevailing situation due to the COVID-19 pandemic and partial lockdowns in various areas of the country.

Besides, the regulator received representations from stock brokers regarding changes to the systems and software development.

In a circular, the Securities and Exchange Board of India (Sebi) said the mechanism of pledge and re-pledge will be implemented with effect from August 1.

Trading members (TMs) or clearing members (CMs) need to align their systems and accept client collateral and margin-funded stocks by way of creation of pledge and re-pledge in the depository system.

It further said TM or CM will also be allowed to accept client securities as collateral by way of title transfer into the client collateral account as per the present system.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"The system of parallel acceptance of the client securities by way of title transfer shall be available only up to August 31, 2020, and no further extension shall be granted," Sebi said.

Funded stocks held by the TM or CM under the margin trading facility will preferably be held by them by way of pledge with effect from August 1.

It further said trading or clearing member may continue to hold funded stocks in respect of margin funding in 'client margin trading securities account' till the end of August.

The regulator reiterated that trading or clearing member will have to close all existing demat accounts tagged as client margin or collateral by August 31.

Earlier in the day, the Association of National Exchanges Members of India (ANMI) has written to Sebi and the finance ministry seeking them "to consider granting extension of implementation of Sebi circular for the next two months and allow the existing system of crediting the funded stock to earmarked funded stock DP account".

In February, Sebi had issued stringent norms to prevent misuse of clients' securities that are available with trading and clearing members, and depository participants.

It had banned transfer of clients' securities to demat accounts of trading and clearing members.

Under the framework, TM or CM will accept collateral from clients in the form of securities, only by way of "margin pledge", created in the depository system, with effect from June 1. This was extended to August 1.

Sebi said depositories should provide "margin pledge" for pledging clients' securities as margin to the TM or CM. The latter should open a separate demat account for accepting such margin pledge, which should be tagged as 'client securities margin pledge account'.

"For the purpose of providing collateral in the form of securities as margin, a client shall pledge securities with TM, and TM shall re-pledge the same with CM, and CM in turn shall re-pledge the same to clearing corporation (CC).

"The complete trail of such re-pledge shall be reflected in the demat account of the pledgor," Sebi had said.
first published: Jul 29, 2020 08:46 pm
ISO 27001 - BSI Assurance Mark